LIMITED POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby authorizes Michael C.
Carroll to execute for and on behalf of the undersigned, in the undersigneds
capacity as a Section 16 reporting person of Biolase, Inc., a Delaware
corporation (the Company), EDGAR Form ID (including amendments thereto) and
Authenticating Statements, Forms 3, 4 and 5, and any amendments thereto, and
cause such form(s) to be filed with the United States Securities and Exchange
Commission and The NASDAQ Stock Market.  The undersigned hereby grants to such
attorney-in-fact full power and authority to do and perform any and every act
and thing whatsoever requisite, necessary, or proper to be done in exercise of
any of the rights and powers herein granted, as fully to all intents and
purposes as the undersigned might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and confirming all that
such attorney-in-fact, or such attorney-in-facts substitute or substitutes,
shall lawfully do or cause to be done by virtue of this power of attorney and
the rights and powers herein granted.

The undersigned acknowledges that the foregoing attorney-in-fact, in serving in
such capacity at the request of the undersigned, is not assuming, nor is the
Company assuming, any of the undersigneds responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934, as amended or the rules
promulgated thereunder.

This Limited Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigneds holdings of, and transactions in, securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 12th day of July, 2022.


By: /s/ Jennifer Bright
Print Name: Jennifer Bright